Abstract
INTRODUCTION:Tetanus is an immuno-preventable disease, produced by the bacterium Clostridium tetani, that causes a disease characterized by muscle spasms, respiratory insufficiency and life-threatening dysautonomia.
MATERIALS AND METHODS:We present a series of three patients who consulted for trismus, muscle stiffness and respiratory failure, which required intensive care management, muscle relaxation, intramuscular and intrathecal administration of tetanus immu-noglobulin, with satisfactory outcomes in all the cases.
DISCUSSION:Its treatment is divided into two main sections; the first part, the control of infection and elimination of the causative agent, with washing and debridement of wounds, administration of antibiotics and neutralization of the neurotoxin. The second part is life support in the intensive care unit, with the administration of sedation, muscular relaxation and control of dysautonomia and the management of complications.
CONCLUSIONS:Despite the advances in vaccination, tetanus is still a present disease, whose diagnosis and rapid and adequate treatment allows patients to survive, as in the cases reported here.
References
Yen LM, Thwaites CL. Tetanus. Lancet. 2019;393(10181):1657-68. DOI: 10.1016/S0140-6736(18)33131-3
Cohen JE, Wang R, Shen R-F, Wu WW, Keller JE. Comparative pathogenomics of Clostridium tetani. PLoS One. 2017;12(8):e0182909. DOI: 10.1371/journal.pone.0182909
Centers for Disease Control and Prevention. Epidemiology and Prevention of Vaccine-Preventable Diseases [Internet]. Washington D.C, Hamborsky J, Kroger A, Wolfe S, eds, 2015 [consultato 2021 Mayo 6]. Disponible en: Disponible en: https://www.cdc.gov/vaccines/pubs/pinkbook/tetanus.html
Kyu HH, Mumford JE, Stanaway JD, Barber RM, Hancock JR, Vos T, Murray CJ, Naghavi M. Mortality from tetanus between 1990 and 2015: findings from the global burden of disease study 2015. BMC Public Health. 2017;17(1). DOI: 10.1186/s12889-017-4111-4
World Health Organization. Weekly epidemiological record No 6, 2017, 92, 53-76 [Internet]. WHO. World Health Organization; 2017. Disponible en: https://apps.who.int/iris/bitstream/handle/10665/254582/WER9206.pdf;jsess ionid=83838F8A4BC481A911EDF6CC34FE4CBF?seque nce=1
Tiwari T, Clark T, Messonnier N, Thomas C. Tetanus surveillance United States, 2001-2008. MMWR Morb Mortal Wkly Rep 2011; 60: 365.
Instituto Nacional de Salud. Informe de evento. Tétanos accidental periodo epidemiológico XII 2019 [Internet]. [citado el 8 de septiembre de 2020]. Disponible en: Disponible en: https://www.ins.gov.co/buscador-eventos/Paginas/Info-Evento.aspx
Vergara I, Gómez A, Pérez G, Rincón R, Fernández G, Calderón F, et al. Tétanos grave. Acta Med Colomb. 1984; (2) 37-42. Disponible en: http://www.actamedicacolombiana.com/anexo/articulos/02-1984-01.pdf
Centers for Disease Control and Prevention. Tetanus, Clinical Information [Internet]. Disponible en: https://www.cdc.gov/tetanus/clinicians.html
Campbell JI, Lam TMY, Huynh TL, To SD, Tran TTN, Nguyen VMH, et al. Microbiologic characterization and antimicrobial susceptibility of Clostridium tetani isolated from wounds of patients with clinically diagnosed tetanus. Am J Trop Med Hyg. 2009;80(5):827-31. DOI: 10.4269/ajtmh.2009.80.827
Birch TB, Bleck TP. Tétanos (Clostridium tetani). En: Bennett JE MD, Dolin R MD, Blaser MJ MD, editores. Mandell, Douglas, Bennett Enfermedades infecciosas Principios y práctica 9na Edición. Barcelona, España: Elsevier; 2021. p. 2948-53.
Megighian, A, Pirazzini, M, Fabris, F, Rossetto, O, Montecucco, C. Tetanus and tetanus neurotoxin: From peripheral uptake to central nervous tissue targets. Review J Neurochem. 2021;158(6):1244-53. DOI:10.1111/jnc.15330
Farrar J, Yen L, Cook T, Fairweather N, Binh N, Parry J, et al. Tetanus. J Neurol Neurosurg Psychiatry 2000; 69: 292-301. DOI: 10.1136/jnnp.69.3.292
Arango-Soto D, Betancur-Franco LA, Aguirre-Muñoz C, Quevedo-Vélez A. Tétanos: todavía un problema de salud pública. Iatreia. 2008;21(1):186-98.
Berkowitz AL. Tetanus, botulism, and diphtheria. Continuum (Minneap Minn). 2018;24(5, Neuroinfectious Dis-ease):1459-88. DOI: 10.1111/jnc.15330
Roper MH, Vandelaer JH, Gasse FL. Maternal and neonatal tetanus. Lancet. 2007;370(9603):1947-59. DOI: 10.1016/S0140-6736(14)60236-1
Rhinesmith E, Fu L. Tetanus disease, treatment, management. Pediatr Rev 2018;39(8):430-2. DOI: 10.1542/pir.2017-0238
Afshar M, Raju M, Ansell D, Bleck TP. Narrative review: tetanus-a health threat after natural disasters in developing countries. Ann Intern Med. 2011;154(5):329-35. DOI: 10.7326/0003-4819-154-5-201103010-00007
Tanon AK, Doumbia A, Coffie PA. Current prognostic factors of tetanus in Abidjan: 2005-2014. J Microbiol Infect Dis. 2017;07(03):125-31. DOI: 10.5799/jmid.367529
Thwaites CL, Yen LM, Glover C, Tuan PQ, Nga NTN, Parry J, et al. Predicting the clinical outcome of tetanus: the tetanus severity score. Trop Med Int Health. 2006;11(3):279-87. DOI: 10.1111/j.1365-3156.2006.01562.x
Sun C, Zhao H, Lu Y, Wang Z, Xue W, Lu S, et al. Prognostic factors for generalized tetanus in adults: A retrospective study in a Chinese hospital. Am J Emerg Med. 2019;37(2):254-9. DOI: 10.1016/j.ajem.2018.05.039
Thwaites CL, Farrar JJ. Preventing and treating tetanus. BMJ. 2003;326(7381):117-8. DOI: 10.1136/bmj.326.7381.117
Murthy JMK, Dastur FD, Khadilkar SV, Kochar DK. Rabies, tetanus, leprosy, and malaria. Biller J, Ferro JM, editors. Handb Clin Neurol. 2014; 121:1501-20. DOI: 10.1016/B978-0-7020-4088-7.00101-2
Taylor AM. Tetanus. Contin Educ Anaesth Crit Care Pain. 2006;6(3):101-4. DOI: 10.1093/bjaceaccp/mkl014
Hanif H, Anjum A, Ali N, Jamal A, Imran M, Ahmad B, Ali MI. Isolation and antibiogram of Clostridium tetani from clinically diagnosed tetanus patients. Am J Trop Med Hyg. 2015;93(4):752-756. DOI:10.4269/ajtmh.15-0040
Campbell JI, Lam TM, Huynh TL, To SD, Tran TT, Nguyen VM, et al. Microbiologic characterization and antimicrobial susceptibility of Clostridium tetani isolated from wounds of patients with clinically diagnosed tetanus. Am J Trop Med Hyg. 2009;80(5):827-31. DOI:org/10.4269/ajtmh.2009.80.827
Ahmadsyah I, Salim A. Treatment of tetanus: an open study to compare the efficacy of procaine penicillin and metronidazole. BMJ. 1985;291(6496):648-50. DOI: 10.1136/bmj.291.6496.648
Ganesh-Kumar AV, Kothari VM, Krishnan A, Karnad DR. Benzathine penicillin, metronidazole and benzyl penicillin in the treatment of tetanus: a randomized, controlled trial. Ann Trop Med Parasitol. 2004;98(1):59-63. DOI: 10.1179/000349804225003037
Rossokhin AV, Sharonova IN, Bukanova JV, Kolbaev SN, Skrebitsky VG. Block of GABA(A) receptor ion channel by penicillin: electrophysiological and modeling insights toward the mechanism. Mol Cell Neurosci. 2014;63:72-82. DOI: 10.1016/j.mcn.2014.10.001
Rodrigo C, Fernando D, Rajapakse S. Pharmacological management of tetanus: an evidence-based review. Crit Care. 2014;18(2):217. DOI: 10.1186/cc13797
Kabura L, Ilibagiza D, Menten J, Van den Ende J. Intrathecal vs. intramuscular administration of human antitetanus immuno-globulin or equine tetanus antitoxin in the treatment of tetanus: a meta-analysis. Trop Med Int Health. 2006;11(7):1075-81. DOI: 10.1111/j.1365-3156.2006.01659.x
Wateba M, Diop S, Nichols S, Patassi A, Adjo S, Gbadamassi G, et al. Intérêt de la thérapie intrathécale à 1 500 UI de sérum antitétanique combinée à 1,5 gramme de métronidazole en intraveineux sur le pronostic du tétanos en milieu hospitalier togolais. Sante. 2008;18(3):125-9. DOI: 10.1684/san.2008.0115
Miranda-Filho D de B, Ximenes RA de A, Barone AA, Vaz VL, Vieira AG, Albuquerque VMG. Randomised controlled trial of tetanus treatment with antitetanus immunoglobulin by the intrathecal or intramuscular route. BMJ. 2004;328(7440):615. DOI.org/10.1136/bmj.38027.560347.7C
Loan HT, Yen LM, Kestelyn E, Van Hao N, Mai NTH, Thuy DB, et al. A pilot study to assess safety and feasibility of intrathecal immunoglobulin for the treatment of adults with tetanus. Am J Trop Med Hyg. 2018;99(2):323-6. DOI: 10.1136/bmj.38027.560347.7C
Hassel B. Tetanus: pathophysiology, treatment, and the possibility of using botulinum toxin against tetanus-induced rigidity and spasms. Toxins (Basel). 2013;5(1):73-83. DOI: 10.3390/toxins5010073
Isono H, Miyagami T, Katayama K, Isono M, Hasegawa R, Gomi H, et al. Tetanus in the elderly: The management of intensive care and prolonged hospitalization. Intern Med. 2016;55(22):3399-402. DOI: 10.2169/internalmedicine.55.7131
Naseem F, Mahar IA, Arif F. Two years' study of tetanus cases in a paediatric intensive care unit. Pak J Med Sci Q. 2016;32(3):641-5. DOI: 10.12669/pjms.323.9165
Petitjeans F, Turc J, Coulet O, Puidupin M, Eve O, Benois A. The use of boluses of propofol for the management of severe tetanus in a child. Trop Doct. 2009;39(1):52-3. DOI: 10.1258/td.2008.080236
Enriquez CAG, Abejero JEE, Ramiro PA, Maligaso CPD. Rocuronium for control of muscle spasms in a tetanus patient with chronic methamphetamine use disorder. BMJ Case Rep 10;2018:bcr2018224391. DOI: 10.1136/bcr-2018-224391
Rodrigo C, Samarakoon L, Fernando SD, Rajapakse S. A meta-analysis of magnesium for tetanus: A meta-analysis of magnesium for tetanus. Anaesthesia. 2012;67(12):1370-1. DOI: 10.1111/anae.12020
Okoromah CN, Lesi FEA. Diazepam for treating tetanus. Cochrane Database Syst Rev. 2004;(1):CD003954. DOI: 10.1002/14651858.CD003954.pub2
Chun P, Ying-Zi H, Yi Y, Hai-Bo Q. Titration of high dose sedation is effective in severe tetanus: a case report. Cases J. 2009;2:6865. DOI: 10.4076/1757-1626-2-6865
Shah B. A review on pharmacological management of generalised tetanus. Gen Med (Los Angel). 2018;06(01). DOI: 10.4172/2327-5146.1000311
Hasnain MG, Maruf S, Nath P, Anuwarul A, Ahmed MNU, Chowdhury IH, et al. Managing severe tetanus without ventilation support in a resource-limited setting in Bangladesh. Am J Trop Med Hyg. 2018;99(5):1234-8. DOI: 10.4269/ajtmh.18-0180
Beigmohammadi MT, Tavakoli F, Safari S, Amiri HR. Sciatic nerve block in tetanus: A case report. Anesth Pain Med. 2015;5(6):e29698. DOI: 10.5812/aapm.29698
Gregorakos L, Kerezoudi E, Dimopoulos G, Thomaides T. Management of blood pressure instability in severe tetanus: the use of clonidine. Intensive Care Med. 1997;23(8):893-5. DOI: 10.1007/s001340050428
Girgin NK, Iscimen R, Gurbet A, Kahveci F, Kutlay O. Dex-medetomidine sedation for the treatment of tetanus in the intensive care unit. Br J Anaesth. 2007;99(4):599-600. DOI: 10.1093/bja/aem251
Rie MA, Wilson RS. Morphine therapy controls autonomic hyperactivity in tetanus. Ann Intern Med. 1978;88(5):653-4 DOI: 10.7326/0003-4819-88-5-653
Bhagwanjee S, Bòsenberg AT, Muckart DJ. Management of sympathetic overactivity in tetanus with epidural bupivacaine and sufentanil: experience with 11 patients. Crit Care Med. 1999;27(9):1721-5. DOI: 10.1097/00003246-19990900000004
Ministerio de salud de Colombia. Información vacunas y programas de vacunación [Internet]. [Consultado el 21 de septiembre de 2020]. Disponible en: Disponible en: https://www.minsalud.gov.co/salud/pubKca/Vacunacion/Paginas/pai.aspx

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
